These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33587847)

  • 21. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
    J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical outcomes with therapies for previously treated recurrent/metastatic head-and-neck squamous cell carcinoma (R/M HNSCC): A systematic literature review.
    Lala M; Chirovsky D; Cheng JD; Mayawala K
    Oral Oncol; 2018 Sep; 84():108-120. PubMed ID: 30115469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of interleukin-7 and interleukin-8 in head and neck squamous cell carcinoma.
    Mojtahedi Z; Khademi B; Erfani N; Taregh Y; Rafati Z; Malekzadeh M; Ghaderi A
    Indian J Cancer; 2014; 51(3):227-230. PubMed ID: 25494110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial.
    Burtness B; Bourhis JP; Vermorken JB; Harrington KJ; Cohen EE
    Trials; 2014 Nov; 15():469. PubMed ID: 25432788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc.
    Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S
    Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
    J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Correlation between prognosis and IL-33 expression in head and neck squamous cell carcinoma].
    Li HQ; Wen YH; Wen WP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jun; 32(12):895-898. PubMed ID: 29921069
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of cytokines in head and neck squamous cell carcinoma: A review.
    Ralli M; Grasso M; Gilardi A; Ceccanti M; Messina MP; Tirassa P; Fiore M; Altissimi G; A Salzano F; De Vincentiis M; Greco A
    Clin Ter; 2020; 171(3):e268-e274. PubMed ID: 32323717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma.
    Chen L; Huang CF; Li YC; Deng WW; Mao L; Wu L; Zhang WF; Zhang L; Sun ZJ
    Cell Mol Life Sci; 2018 Jun; 75(11):2045-2058. PubMed ID: 29184980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining cancer cachexia in head and neck squamous cell carcinoma.
    Richey LM; George JR; Couch ME; Kanapkey BK; Yin X; Cannon T; Stewart PW; Weissler MC; Shores CG
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6561-7. PubMed ID: 18006755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma.
    Druzgal CH; Chen Z; Yeh NT; Thomas GR; Ondrey FG; Duffey DC; Vilela RJ; Ende K; McCullagh L; Rudy SF; Muir C; Herscher LL; Morris JC; Albert PS; Van Waes C
    Head Neck; 2005 Sep; 27(9):771-84. PubMed ID: 15920746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calprotectin and the Initiation and Progression of Head and Neck Cancer.
    Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC
    J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
    J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulated interleukin-6 expression contributes to erlotinib resistance in head and neck squamous cell carcinoma.
    Stanam A; Love-Homan L; Joseph TS; Espinosa-Cotton M; Simons AL
    Mol Oncol; 2015 Aug; 9(7):1371-83. PubMed ID: 25888065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytokine expression of transforming growth factor-beta2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels].
    Karcher J; Reisser C; Daniel V; Herold-Mende C
    HNO; 1999 Oct; 47(10):879-84. PubMed ID: 10550371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-tumor effects of metformin on head and neck carcinoma cell lines: A systematic review.
    Rêgo DF; Elias ST; Amato AA; Canto GL; Guerra EN
    Oncol Lett; 2017 Feb; 13(2):554-566. PubMed ID: 28356929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The soluble alpha chain of interleukin-15 receptor: a proinflammatory molecule associated with tumor progression in head and neck cancer.
    Badoual C; Bouchaud G; Agueznay Nel H; Mortier E; Hans S; Gey A; Fernani F; Peyrard S; -Puig PL; Bruneval P; Sastre X; Plet A; Garrigue-Antar L; Quintin-Colonna F; Fridman WH; Brasnu D; Jacques Y; Tartour E
    Cancer Res; 2008 May; 68(10):3907-14. PubMed ID: 18483276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
    Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
    Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
    Scher RL
    Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma.
    Wu D; Cheng J; Sun G; Wu S; Li M; Gao Z; Zhai S; Li P; Su D; Wang X
    Oncotarget; 2016 Jun; 7(24):36539-36550. PubMed ID: 27174914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.